MEDIGENE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.33 EUR | -4.32% |
|
-11.74% | -13.77% |
| 12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
| May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDIGENE AG | Bio Therapeutic Drugs | -5.40% | -11.74% | -13.77% | -18.83% | -83.83% | 37.08M |  | | |
- Stock Market
- Equities
- MDG1 Stock
- Charts Medigene AG
- Relative Strength Chart